Kailera Therapeutics Inc. logo

Kailera Therapeutics Inc.

KLRA | NASDAQ
Chart Builder DCF Calculator
$12.92
+$0.06 (+0.47%)
Nov 2, 2026, 10:06 AM ET · Market open
Fiscal Quarter
Period Ending
Q2 2026
Jun 30, 2026
Q1 2026
Mar 31, 2026
Revenue
n/a n/a
Cost of Revenue
n/a n/a
Gross Profit
n/a n/a
Operating Income
-121.37M -84.66M
Interest Income
9.99M 5.72M
Pretax Income
-111.31M -78.87M
Net Income
-111.31M -78.87M
Selling & General & Admin
20.31M 13.79M
Research & Development
101.06M 70.87M
Other Expenses
n/a n/a
Operating Expenses
121.37M 84.66M
Interest Expense
n/a n/a
Selling & Marketing Expenses
n/a n/a
Cost & Expenses
121.37M 84.66M
Income Tax Expense
n/a n/a
Shares Outstanding (Basic)
102.23M 117.95M
Shares Outstanding (Diluted)
102.23M 117.95M
EPS (Basic)
-1.09 -0.67
EPS (Diluted)
-1.09 -0.67
EBITDA
-111.31M -84.56M
EBIT
-111.31M -84.66M
Depreciation & Amortization
n/a 101K

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.